Albrecht J
Department of Neuropathology, Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland.
Toxicol Lett. 1991 Dec;59(1-3):133-8. doi: 10.1016/0378-4274(91)90064-d.
Intraperitoneal administration of a single dose (6 mg/kg body wt.) of mercuric chloride led to a rapid and irreversible inhibition of Na+/K(+)-ATPase activity in rat cerebral capillaries. The activity measured at 1 h, 18 h and 5 days after injection was, respectively, 53, 44 and 26% of the control. By contrast, Mg(2+)-ATPase activity in the capillaries remained uninhibited throughout the observation period. Mercuric chloride administration did not affect either of the two enzyme activities in nerve endings, which is consistent with the inability of the compound to penetrate the blood-brain barrier. The mercuric-chloride-induced impairment of the capillary sodium pump may contribute to disturbances of ion homeostasis in the brain and thus to the neurophysiological abnormalities accompanying this exposure. Direct treatment of the isolated cerebral capillary preparations with mercuric chloride evoked a stronger inhibitory effect on Mg(2+)-ATPase (IC50 = 0.25 microM) than on Na+/K(+)-ATPase (IC50 = 5.0 microM). This result indicates that the effect in vivo may not have resulted from direct interaction of the compound with the latter enzyme.
腹腔注射单剂量(6毫克/千克体重)的氯化汞会导致大鼠脑毛细血管中Na+/K(+)-ATP酶活性迅速且不可逆地受到抑制。注射后1小时、18小时和5天测得的活性分别为对照组的53%、44%和26%。相比之下,在整个观察期内,毛细血管中的Mg(2+)-ATP酶活性未受抑制。氯化汞的给药对神经末梢中的这两种酶活性均无影响,这与该化合物无法穿透血脑屏障相一致。氯化汞诱导的毛细血管钠泵损伤可能导致大脑中离子稳态的紊乱,进而导致伴随这种暴露的神经生理异常。用氯化汞直接处理分离的脑毛细血管制剂对Mg(2+)-ATP酶(IC50 = 0.25微摩尔)的抑制作用比对Na+/K(+)-ATP酶(IC50 = 5.0微摩尔)更强。这一结果表明,体内效应可能并非该化合物与后一种酶直接相互作用所致。